Furthermore, with sorafenib treatment, CBX4 overexpression in Huh7 rapidly drives tumour growth; however, this characteristic was specifically inhibited by as much as 85% when Huh7 CBX4-overexpressing cells were treated with miR424 (Fig. 4e–g). The gene discussed is CBX4; the disease is neoplasm.